Nuvation Bio Inc expected to post a loss of 10 cents a share - Earnings Preview

Nuvation Bio

30/04/2024 13:03

* Nuvation Bio Inc  NUVB.N   NUVB.K  is expected to show no
change
in quarterly revenue when it reports  results on May 2
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Nuvation Bio Inc is for
a loss
of 10 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Nuvation
Bio Inc
is $5.00​, above​ its last closing price of $2.95. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.09       -0.10      -0.06     Beat    42.8
 Jan. 1 2023   -0.11       -0.11      -0.09     Beat    17.9
 Jun. 30 2023  -0.11       -0.11      -0.09     Beat    19.5​
 Mar. 31 2023  -0.10       -0.10      -0.10     Met     0
 ​​Dec.        -0.08       -0.11      -0.10     Beat    13
 31 2022                                                
 Sep. 30 2022  -0.14       -0.14      -0.12     Beat    14.3​
 Jun. 30 2022  -0.13       -0.13      -0.16     Missed  -20.4
 Jan. 1 0001   -0.14       -0.14      -0.10     Beat    30.6
 This summary was machine generated April 30 at 12:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)